Ilika begins trading on the OTCQX Best Market in the U.S.

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, is pleased to announce that trading in the Company’s ordinary shares will begin today on the OTCQX Best Market, in the United States, under the ticker symbol “ILIKF”. Ilika has upgraded to OTCQX from the Pink® market.

Trading on OTCQX is an important step for Ilika, in addition to the AIM listing it gives the business exposure to a wider audience of potential investors by easing cross-border trading for our US investors. By trading on the premium OTCQX, Ilika’s shares will be available to US investors during US working hours and priced in US dollars and has the potential to increase liquidity in Ilika’s shares on AIM. Ilika’s shares will continue to trade on the London Stock Exchange’s AIM market under the symbol “IKA”.

Graeme Purdy, Ilika plc CEO commented, “We are very pleased to be graduating to the OTCQX Market. This will provide our valued US investors with greater liquidity and execution services through OTCQX. It will also help us to build our visibility among US investors.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Search

Search